Moderna

Moderna is a biotechnology company at the forefront of mRNA therapeutics and vaccines. Since its inception, the company has focused on creating a new class of medicines that instruct the body to produce proteins that can prevent, treat, or cure a wide range of diseases. Their platform is built on the foundation of messenger RNA (mRNA) science, which allows for rapid development and scalability of therapeutic candidates. Following the global success of its COVID-19 vaccine, Moderna has significantly expanded its pipeline to include clinical-stage programs targeting infectious diseases, immuno-oncology, rare diseases, and cardiovascular conditions. The company operates with a high-tech, data-driven approach to drug discovery, aiming to transform the future of medicine through its proprietary mRNA technology platform.

Mission: To deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.

• Developed one of the first and most widely used mRNA-based COVID-19 vaccines.
• Pioneered the clinical application of mRNA technology for human therapeutics.
• Maintains a robust and diverse clinical pipeline across multiple therapeutic areas.
• Recognized for rapid innovation and scaling capabilities in vaccine manufacturing.

Sources

• Moderna Official Website
• NASDAQ Moderna Profile